Evidence map›Paper›PMID 34984249›Full record

ReviewACS omega2021

Catalytic Transformation of Biomass-Derived Furfurals to Cyclopentanones and Their Derivatives: A Review.

Saikat Dutta, Navya Subray Bhat

Abstract readReview
In one paragraph

Review in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Tailoring Cu-SiOACS applied materials & interfaces · 2025
    Review
  3. C2 to C6 biobased carbonyl platforms for fine chemistry.Beilstein journal of organic chemistry · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Saikat DuttaDepartment of Chemistry, National Institute of Technology Karnataka, Mangalore 575025, Karnataka, India.ORCID https://orcid.org/0000-0003-3310-348X
Navya Subray BhatDepartment of Chemistry, National Institute of Technology Karnataka, Mangalore 575025, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Furfural (FF) and 5-(hydroxymethyl)furfural (HMF) are well-recognized biomass-derived chemical building blocks with established applications and markets for several of their derivatives. Attaining a wide spectrum of petrochemicals is the primary target of a biorefinery that employs FF and HMF as the chemical feedstock. In this regard, cyclopentanone (CPN) is a crucial petrochemical intermediate used for synthesizing a diverse range of compounds with immense commercial prospects. The hydrogenative ring rearrangement of FF to CPN in an aqueous medium under catalytic hydrogenation conditions was first reported in 2012, whereas the first report on the catalytic conversion of HMF to 3-(hydroxymethyl)cyclopentanone (HCPN) was published in 2014. Over the past decade, several investigations have been undertaken in converting FF and HMF to CPN and HCPN, respectively. The research studies aimed to improve the scalability, selectivity, environmental footprint, and cost competitiveness of the process. A blend of theoretical and experimental studies has helped to develop efficient, inexpensive, and recyclable heterogeneous catalysts that work under mild reaction conditions while providing excellent yields of CPN and HCPN. The time is ripe to consolidate the data in this area of research and analyze them rigorously in a review article. This work will assist both beginners and experts of this field in acknowledging the accomplishments to date, recognize the challenges, and strategize the way forward.

Identifiers

PMID34984249
PMCPMC8717399

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.